This model adequately captured our observed results and described the differentiation of NKTR-214 relative to aldesleukin not only with respect to PK, but also with respect to the receptor-binding dynamics that ultimately lead to significant immunological effects in the tumor microenvironment. Here, IL2 is linked to neoplasm.